(Q33427566)

English

Previstage GCC colorectal cancer staging test: a new molecular test to identify lymph node metastases and provide more accurate information about the stage of patients with colorectal cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

Previstage GCC colorectal cancer staging test: a new molecular test to identify lymph node metastases and provide more accurate information about the stage of patients with colorectal cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Marilyn R Carlson

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Molecular Diagnosis and Therapy

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

11-14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FBF03256309

21 January 2018

Colorectal cancer staging and adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FBF03256309

21 January 2018

Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FBF03256309

21 January 2018

Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature.

1 reference

https://api.crossref.org/works/10.1007%2FBF03256309

21 January 2018

Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1007%2FBF03256309

21 January 2018

A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FBF03256309

21 January 2018

Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FBF03256309

21 January 2018

Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FBF03256309

21 January 2018

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19351210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF03256309

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33427566&oldid=2195352168"